CN Stock MarketDetailed Quotes

600420 Shanghai Shyndec Pharmaceutical

Watchlist
  • 11.40
  • -0.13-1.13%
Market Closed May 23 15:00 CST
15.29BMarket Cap18.12P/E (TTM)

Shanghai Shyndec Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-8.60%3.12B
-6.86%12.07B
-5.73%9.16B
0.90%6.44B
5.33%3.42B
-7.07%12.96B
-9.25%9.72B
-16.31%6.39B
-17.42%3.24B
11.06%13.94B
Operating revenue
-8.60%3.12B
-6.86%12.07B
-5.73%9.16B
0.90%6.44B
5.33%3.42B
-7.07%12.96B
-9.25%9.72B
-16.31%6.39B
-17.42%3.24B
11.06%13.94B
Other operating revenue
----
88.93%282.98M
----
163.15%174.44M
----
-20.77%149.79M
----
-75.43%66.29M
----
27.75%189.06M
Total operating cost
-14.65%2.63B
-8.67%11B
-8.52%8.25B
-2.67%5.8B
1.15%3.08B
-6.64%12.04B
-8.30%9.01B
-14.22%5.96B
-14.44%3.04B
11.55%12.9B
Operating cost
-9.00%1.85B
-7.23%7.44B
-4.36%5.6B
3.33%3.92B
9.21%2.03B
2.25%8.02B
-1.97%5.86B
-12.05%3.79B
-12.99%1.86B
18.10%7.85B
Operating tax surcharges
32.16%38.4M
20.82%138.12M
18.67%95.65M
19.85%65.28M
3.45%29.06M
-11.67%114.32M
-16.54%80.6M
-16.83%54.47M
-23.43%28.09M
1.65%129.43M
Operating expense
-36.65%453.6M
-21.59%2.15B
-23.66%1.67B
-16.12%1.25B
-13.14%715.99M
-21.19%2.75B
-20.65%2.19B
-21.93%1.49B
-22.43%824.29M
2.59%3.48B
Administration expense
7.40%184.15M
12.59%770.07M
-7.27%552.88M
-11.18%359.97M
-8.04%171.46M
-8.72%683.97M
8.94%596.23M
11.60%405.3M
5.07%186.45M
1.73%749.3M
Financial expense
-222.74%-21.07M
-63.65%-75.49M
24.61%-51.72M
-56.72%-39.83M
-31.24%17.17M
-146.12%-46.13M
-203.53%-68.6M
-151.42%-25.42M
85.67%24.97M
-37.62%100.02M
-Interest expense (Financial expense)
-46.32%9.47M
-46.06%57.88M
-43.15%48.06M
-36.80%37.75M
-41.54%17.65M
-2.86%107.31M
-0.62%84.54M
10.27%59.73M
19.73%30.19M
-10.56%110.47M
-Interest Income (Financial expense)
-37.78%-22.84M
-83.71%-109.02M
-81.23%-73.6M
-98.16%-49.07M
-47.38%-16.58M
-21.51%-59.35M
-22.57%-40.61M
-21.07%-24.76M
-23.29%-11.25M
-32.79%-48.84M
Research and development
9.92%121.61M
9.31%569.43M
4.67%376.89M
1.69%243.58M
-5.44%110.63M
-11.59%520.92M
-6.77%360.09M
-1.98%239.54M
-7.31%117M
18.09%589.18M
Credit Impairment Loss
78.39%-2.76M
2.64%18.05M
-175.11%-3.59M
1.47%-16.57M
46.18%-12.75M
170.73%17.59M
116.03%4.78M
61.22%-16.81M
13.66%-23.7M
5.22%-24.87M
Asset Impairment Loss
76.34%-3.25M
-69.38%-79.11M
-8.26%-51.24M
-33.71%-28.3M
-123.57%-13.74M
73.43%-46.7M
-205.31%-47.34M
-101.55%-21.16M
-664.21%-6.15M
-134.44%-175.79M
Other net revenue
257.16%27.75M
-77.62%11.37M
-122.52%-3.55M
-2,157.63%-38.09M
6.18%-17.66M
134.67%50.8M
188.70%15.77M
104.37%1.85M
26.92%-18.82M
-541.94%-146.53M
Fair value change income
----
----
----
---3.85M
----
----
----
----
----
----
Invest income
269.21%2.48M
1,071.97%27.45M
432.67%13.47M
-1,012.23%-8.01M
69.07%-1.47M
109.74%2.34M
74.52%-4.05M
95.96%-720.17K
40.92%-4.74M
-10.23%-24.04M
-Including: Investment income associates
3.98%-1.14M
13.24%5.6M
-88.44%-6.15M
-539.38%-5.28M
75.47%-1.19M
146.51%4.95M
72.18%-3.26M
92.39%-825.61K
17.17%-4.84M
40.81%-10.64M
Asset deal income
-2,260.59%-2.2M
-2,785.98%-31.85M
-252.57%-1.2M
-515.62%-1M
-107.35%-93.09K
-644.14%-1.1M
268.09%788.53K
-181.64%-163.14K
504.00%1.27M
-99.15%202.79K
Other revenue
221.94%33.47M
-2.37%76.81M
-36.64%39.02M
-51.75%19.64M
-28.26%10.4M
0.91%78.68M
42.40%61.58M
40.00%40.71M
33.85%14.49M
-41.06%77.97M
Operating profit
62.77%524.6M
11.95%1.08B
26.55%913.15M
41.28%604.93M
75.97%322.29M
7.64%966.14M
-16.40%721.57M
-33.23%428.16M
-47.26%183.15M
-12.36%897.56M
Add:Non operating Income
-72.33%802.85K
-41.53%25.49M
-44.74%22.05M
110.08%18.17M
-28.44%2.9M
-7.76%43.59M
-22.34%39.9M
-26.72%8.65M
187.89%4.05M
50.85%47.26M
Less:Non operating expense
2,501.30%17.4M
-58.77%10.56M
-46.17%9.58M
-53.01%5.53M
-87.92%668.89K
-3.78%25.61M
-0.91%17.8M
-14.45%11.78M
12.25%5.54M
84.87%26.61M
Total profit
56.54%508M
11.43%1.1B
24.47%925.61M
45.30%617.56M
78.64%324.53M
7.18%984.12M
-17.05%743.66M
-33.51%425.03M
-47.15%181.67M
-11.81%918.21M
Less:Income tax cost
63.42%82.15M
13.13%131.95M
-8.16%128.11M
8.44%103.04M
10.26%50.27M
20.16%116.63M
44.02%139.49M
-3.29%95.02M
-14.21%45.59M
-31.20%97.06M
Net profit
55.27%425.86M
11.20%964.61M
32.00%797.5M
55.91%514.52M
101.54%274.26M
5.64%867.48M
-24.45%604.17M
-39.00%330.02M
-53.17%136.08M
-8.77%821.15M
Net profit from continuing operation
55.27%425.86M
11.20%964.61M
32.00%797.5M
55.91%514.52M
101.54%274.26M
5.64%867.48M
-24.45%604.17M
-39.00%330.02M
-53.17%136.08M
-8.77%821.15M
Less:Minority Profit
-0.46%94.6M
13.78%272.73M
31.37%233.58M
61.25%169.58M
62.60%95.04M
-5.21%239.69M
5.68%177.8M
-8.48%105.17M
-16.36%58.45M
0.64%252.87M
Net profit of parent company owners
84.83%331.26M
10.21%691.88M
32.26%563.92M
53.41%344.94M
130.87%179.22M
10.47%627.79M
-32.48%426.37M
-47.23%224.85M
-64.83%77.63M
-12.41%568.28M
Earning per share
Basic earning per share
61.54%0.247
-11.12%0.5433
8.57%0.4508
30.65%0.286
102.25%0.1529
10.46%0.6113
-32.48%0.4152
-47.24%0.2189
-64.82%0.0756
-12.41%0.5534
Diluted earning per share
79.51%0.247
0.07%0.5433
21.94%0.4508
45.55%0.286
99.71%0.1376
12.52%0.5429
-30.90%0.3697
-45.57%0.1965
-63.14%0.0689
-12.29%0.4825
Other composite income
-81.75%90.8K
-109.10%-74.08K
-218.27%-73.77K
-108.42%-33.46K
96.61%497.48K
21.42%814.02K
-105.82%-23.18K
-23.47%397.24K
672.43%253.03K
Other composite income of parent company owners
----
-81.75%90.8K
-109.10%-74.08K
-218.27%-73.77K
-108.42%-33.46K
96.61%497.48K
21.42%814.02K
-105.82%-23.18K
-23.47%397.24K
672.43%253.03K
Total composite income
55.29%425.86M
11.14%964.7M
31.81%797.43M
55.90%514.45M
100.93%274.23M
5.67%867.98M
-24.41%604.99M
-39.05%329.99M
-53.12%136.48M
-8.74%821.4M
Total composite income of parent company owners
84.86%331.26M
10.14%691.97M
31.99%563.85M
53.39%344.87M
129.65%179.19M
10.51%628.29M
-32.42%427.19M
-47.29%224.83M
-64.73%78.03M
-12.37%568.53M
Total composite income of minority owners
-0.46%94.6M
13.78%272.73M
31.37%233.58M
61.25%169.58M
62.60%95.04M
-5.21%239.69M
5.68%177.8M
-8.48%105.17M
-16.36%58.45M
0.64%252.87M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -8.60%3.12B-6.86%12.07B-5.73%9.16B0.90%6.44B5.33%3.42B-7.07%12.96B-9.25%9.72B-16.31%6.39B-17.42%3.24B11.06%13.94B
Operating revenue -8.60%3.12B-6.86%12.07B-5.73%9.16B0.90%6.44B5.33%3.42B-7.07%12.96B-9.25%9.72B-16.31%6.39B-17.42%3.24B11.06%13.94B
Other operating revenue ----88.93%282.98M----163.15%174.44M-----20.77%149.79M-----75.43%66.29M----27.75%189.06M
Total operating cost -14.65%2.63B-8.67%11B-8.52%8.25B-2.67%5.8B1.15%3.08B-6.64%12.04B-8.30%9.01B-14.22%5.96B-14.44%3.04B11.55%12.9B
Operating cost -9.00%1.85B-7.23%7.44B-4.36%5.6B3.33%3.92B9.21%2.03B2.25%8.02B-1.97%5.86B-12.05%3.79B-12.99%1.86B18.10%7.85B
Operating tax surcharges 32.16%38.4M20.82%138.12M18.67%95.65M19.85%65.28M3.45%29.06M-11.67%114.32M-16.54%80.6M-16.83%54.47M-23.43%28.09M1.65%129.43M
Operating expense -36.65%453.6M-21.59%2.15B-23.66%1.67B-16.12%1.25B-13.14%715.99M-21.19%2.75B-20.65%2.19B-21.93%1.49B-22.43%824.29M2.59%3.48B
Administration expense 7.40%184.15M12.59%770.07M-7.27%552.88M-11.18%359.97M-8.04%171.46M-8.72%683.97M8.94%596.23M11.60%405.3M5.07%186.45M1.73%749.3M
Financial expense -222.74%-21.07M-63.65%-75.49M24.61%-51.72M-56.72%-39.83M-31.24%17.17M-146.12%-46.13M-203.53%-68.6M-151.42%-25.42M85.67%24.97M-37.62%100.02M
-Interest expense (Financial expense) -46.32%9.47M-46.06%57.88M-43.15%48.06M-36.80%37.75M-41.54%17.65M-2.86%107.31M-0.62%84.54M10.27%59.73M19.73%30.19M-10.56%110.47M
-Interest Income (Financial expense) -37.78%-22.84M-83.71%-109.02M-81.23%-73.6M-98.16%-49.07M-47.38%-16.58M-21.51%-59.35M-22.57%-40.61M-21.07%-24.76M-23.29%-11.25M-32.79%-48.84M
Research and development 9.92%121.61M9.31%569.43M4.67%376.89M1.69%243.58M-5.44%110.63M-11.59%520.92M-6.77%360.09M-1.98%239.54M-7.31%117M18.09%589.18M
Credit Impairment Loss 78.39%-2.76M2.64%18.05M-175.11%-3.59M1.47%-16.57M46.18%-12.75M170.73%17.59M116.03%4.78M61.22%-16.81M13.66%-23.7M5.22%-24.87M
Asset Impairment Loss 76.34%-3.25M-69.38%-79.11M-8.26%-51.24M-33.71%-28.3M-123.57%-13.74M73.43%-46.7M-205.31%-47.34M-101.55%-21.16M-664.21%-6.15M-134.44%-175.79M
Other net revenue 257.16%27.75M-77.62%11.37M-122.52%-3.55M-2,157.63%-38.09M6.18%-17.66M134.67%50.8M188.70%15.77M104.37%1.85M26.92%-18.82M-541.94%-146.53M
Fair value change income ---------------3.85M------------------------
Invest income 269.21%2.48M1,071.97%27.45M432.67%13.47M-1,012.23%-8.01M69.07%-1.47M109.74%2.34M74.52%-4.05M95.96%-720.17K40.92%-4.74M-10.23%-24.04M
-Including: Investment income associates 3.98%-1.14M13.24%5.6M-88.44%-6.15M-539.38%-5.28M75.47%-1.19M146.51%4.95M72.18%-3.26M92.39%-825.61K17.17%-4.84M40.81%-10.64M
Asset deal income -2,260.59%-2.2M-2,785.98%-31.85M-252.57%-1.2M-515.62%-1M-107.35%-93.09K-644.14%-1.1M268.09%788.53K-181.64%-163.14K504.00%1.27M-99.15%202.79K
Other revenue 221.94%33.47M-2.37%76.81M-36.64%39.02M-51.75%19.64M-28.26%10.4M0.91%78.68M42.40%61.58M40.00%40.71M33.85%14.49M-41.06%77.97M
Operating profit 62.77%524.6M11.95%1.08B26.55%913.15M41.28%604.93M75.97%322.29M7.64%966.14M-16.40%721.57M-33.23%428.16M-47.26%183.15M-12.36%897.56M
Add:Non operating Income -72.33%802.85K-41.53%25.49M-44.74%22.05M110.08%18.17M-28.44%2.9M-7.76%43.59M-22.34%39.9M-26.72%8.65M187.89%4.05M50.85%47.26M
Less:Non operating expense 2,501.30%17.4M-58.77%10.56M-46.17%9.58M-53.01%5.53M-87.92%668.89K-3.78%25.61M-0.91%17.8M-14.45%11.78M12.25%5.54M84.87%26.61M
Total profit 56.54%508M11.43%1.1B24.47%925.61M45.30%617.56M78.64%324.53M7.18%984.12M-17.05%743.66M-33.51%425.03M-47.15%181.67M-11.81%918.21M
Less:Income tax cost 63.42%82.15M13.13%131.95M-8.16%128.11M8.44%103.04M10.26%50.27M20.16%116.63M44.02%139.49M-3.29%95.02M-14.21%45.59M-31.20%97.06M
Net profit 55.27%425.86M11.20%964.61M32.00%797.5M55.91%514.52M101.54%274.26M5.64%867.48M-24.45%604.17M-39.00%330.02M-53.17%136.08M-8.77%821.15M
Net profit from continuing operation 55.27%425.86M11.20%964.61M32.00%797.5M55.91%514.52M101.54%274.26M5.64%867.48M-24.45%604.17M-39.00%330.02M-53.17%136.08M-8.77%821.15M
Less:Minority Profit -0.46%94.6M13.78%272.73M31.37%233.58M61.25%169.58M62.60%95.04M-5.21%239.69M5.68%177.8M-8.48%105.17M-16.36%58.45M0.64%252.87M
Net profit of parent company owners 84.83%331.26M10.21%691.88M32.26%563.92M53.41%344.94M130.87%179.22M10.47%627.79M-32.48%426.37M-47.23%224.85M-64.83%77.63M-12.41%568.28M
Earning per share
Basic earning per share 61.54%0.247-11.12%0.54338.57%0.450830.65%0.286102.25%0.152910.46%0.6113-32.48%0.4152-47.24%0.2189-64.82%0.0756-12.41%0.5534
Diluted earning per share 79.51%0.2470.07%0.543321.94%0.450845.55%0.28699.71%0.137612.52%0.5429-30.90%0.3697-45.57%0.1965-63.14%0.0689-12.29%0.4825
Other composite income -81.75%90.8K-109.10%-74.08K-218.27%-73.77K-108.42%-33.46K96.61%497.48K21.42%814.02K-105.82%-23.18K-23.47%397.24K672.43%253.03K
Other composite income of parent company owners -----81.75%90.8K-109.10%-74.08K-218.27%-73.77K-108.42%-33.46K96.61%497.48K21.42%814.02K-105.82%-23.18K-23.47%397.24K672.43%253.03K
Total composite income 55.29%425.86M11.14%964.7M31.81%797.43M55.90%514.45M100.93%274.23M5.67%867.98M-24.41%604.99M-39.05%329.99M-53.12%136.48M-8.74%821.4M
Total composite income of parent company owners 84.86%331.26M10.14%691.97M31.99%563.85M53.39%344.87M129.65%179.19M10.51%628.29M-32.42%427.19M-47.29%224.83M-64.73%78.03M-12.37%568.53M
Total composite income of minority owners -0.46%94.6M13.78%272.73M31.37%233.58M61.25%169.58M62.60%95.04M-5.21%239.69M5.68%177.8M-8.48%105.17M-16.36%58.45M0.64%252.87M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg